FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

1495581000168106: List of Medicines for Brand Consideration reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Sep 2020. Module: Third party reference set module

Descriptions:

Id Description Lang Type Status Case? Module
4462321000168116 List of Medicines for Brand Consideration reference set (foundation metadata concept) en Fully specified name Active Initial character case insensitive Third party reference set module
4462331000168118 List of Medicines for Brand Consideration reference set en Synonym Active Initial character case insensitive Third party reference set module
4462411000168119 List of Medicines for Brand Consideration (LMBC) reference set en Synonym Active Initial character case insensitive Third party reference set module
4462641000168118 <p>Supports the identification of AMT Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP) concepts associated with the List of Medicines for Brand Consideration (LMBC) that forms part of the Active Ingredient Prescribing initiative. Under the <i>National Health (Pharmaceutical Benefits) Regulations 2017</i>, the <i>Repatriation Pharmaceutical Benefits Scheme Instrument 2013</i> and <i>MRCA Pharmaceutical Benefits Scheme Instrument 2013</i>, all PBS and RPBS prescriptions must be prepared by active ingredient, the brand may additionally be identified if a prescriber considers it necessary. The LMBC supports prescribers' decision-making regarding the inclusion of brand on a prescription.</p><p>This reference set can be used by prescribing software vendors to identify medications for brand consideration to meet Active Ingredient Prescribing requirements.</p><p><b>Target Client:&nbsp;</b>This reference set was developed by the National Clinical Terminology Service for the Australian Government Department of Health and Aged Care to support the Active Ingredient Prescribing initiative, and can be used by developers to assist with the requirements.</p> en Definition Active Case sensitive Third party reference set module


1324 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
List of Medicines for Brand Consideration reference set Is a Reference sets for Medications true Inferred relationship Some
List of Medicines for Brand Consideration reference set Is a Simple type reference set true Inferred relationship Some
List of Medicines for Brand Consideration reference set Developed by Australian Government Department of Health and Aged Care true Inferred relationship Some 1570063879

Members
buprenorphine 8 mg sublingual tablet, 28
buprenorphine 8 mg sublingual tablet, 7 tablets (medicinal product pack)
buprenorphine 8.6 mg + naloxone 2.1 mg sublingual tablet
buprenorphine 8.6 mg + naloxone 2.1 mg sublingual tablet, 28
buprenorphine 8.6 mg + naloxone 2.1 mg sublingual tablet, 30
buprenorphine 8.6 mg + naloxone 2.1 mg sublingual tablet, 7
buprenorphine 96 mg/0.27 mL modified release injection, syringe
buprenorphine 96 mg/0.27 mL modified release injection, 0.27 mL syringe
carbamazepine 200 mg modified release tablet
carbamazepine 200 mg modified release tablet, 200
carbamazepine 200 mg tablet
carbamazepine 200 mg tablet, 100
carbamazepine 200 mg tablet, 1000
carbamazepine 200 mg tablet, 200
ciclosporin 10 mg capsule
ciclosporin 10 mg capsule, 60
ciclosporin 100 mg/mL oral liquid
ciclosporin 100 mg/mL oral liquid, 50 mL
ciclosporin 100 mg capsule
ciclosporin 100 mg capsule, 30
ciclosporin 100 mg capsule, 50
ciclosporin 100 mg capsule, 60
ciclosporin 25 mg capsule
ciclosporin 25 mg capsule, 30
ciclosporin 25 mg capsule, 50
ciclosporin 25 mg capsule, 60
ciclosporin 50 mg/mL injection, ampoule
ciclosporin 50 mg/mL injection, 10 x 1 mL ampoules
ciclosporin 50 mg capsule
ciclosporin 50 mg capsule, 30
ciclosporin 50 mg capsule, 50
ciclosporin 50 mg capsule, 60
clostridium botulinum type A toxin-haemagglutinin complex 125 units injection, 1 vial
clostridium botulinum type A toxin-haemagglutinin complex 125 units injection, vial
clostridium botulinum type A toxin-haemagglutinin complex 125 units injection, 2 vials
clostridium botulinum type A toxin-haemagglutinin complex 300 units injection, 1 vial
clostridium botulinum type A toxin-haemagglutinin complex 300 units injection, vial
clostridium botulinum type A toxin-haemagglutinin complex 500 units injection, 1 vial
clostridium botulinum type A toxin-haemagglutinin complex 500 units injection, vial
clozapine 100 mg tablet
clozapine 100 mg tablet, 100
clozapine 100 mg tablet, 28
clozapine 100 mg tablet, 50
clozapine 200 mg tablet
clozapine 200 mg tablet, 100
clozapine 200 mg tablet, 50
clozapine 25 mg tablet
clozapine 25 mg tablet, 100
clozapine 25 mg tablet, 28
clozapine 25 mg tablet, 50
clozapine 50 mg/mL oral liquid
clozapine 50 mg/mL oral liquid, 100 mL
clozapine 50 mg tablet
clozapine 50 mg tablet, 100
clozapine 50 mg tablet, 50
cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet
cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28
cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 3 x 28
desogestrel 150 microgram + ethinylestradiol 30 microgram tablet
desogestrel 150 microgram + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28
estradiol valerate 2 mg + dienogest 2 mg tablet
dienogest 2 mg + ethinylestradiol 30 microgram tablet
dienogest 2 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28
dienogest 2 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28
estradiol valerate 2 mg + dienogest 3 mg tablet
dorzolamide 2% + timolol 0.5% eye drops
dorzolamide 2% + timolol 0.5% eye drops, 5 mL
dorzolamide 20 mg / 1 mL eye drops (medicinal product unit of use)
dorzolamide 2% eye drops, 5 mL
dorzolamide 2% + timolol 0.5% eye drops, unit dose
dorzolamide 2% + timolol 0.5% eye drops, 15 x 0.2 mL unit doses
dorzolamide 2% + timolol 0.5% eye drops, 60 x 0.2 mL unit doses
estradiol 1 mg + drospirenone 2 mg tablet
estradiol 1 mg + drospirenone 2 mg tablet, 112
estradiol 1 mg + drospirenone 2 mg tablet, 28
estradiol 1 mg + drospirenone 2 mg tablet, 56
estradiol 1 mg + drospirenone 2 mg tablet, 84
estetrol 14.2 mg + drospirenone 3 mg tablet
drospirenone 3 mg + ethinylestradiol 20 microgram tablet
drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 2 x 28
drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 28
drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 3 x 28
drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 4 x 28
drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 6 x 28
drospirenone 3 mg + ethinylestradiol 20 microgram tablet, 30
drospirenone 3 mg + ethinylestradiol 20 microgram tablet, 4 x 30
drospirenone 3 mg + ethinylestradiol 30 microgram tablet
drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 2 x 28
drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28
drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28
drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 4 x 28
estradiol 1 mg tablet [14] (&) estradiol 1 mg + dydrogesterone 10 mg tablet [14], 28
estradiol 2 mg tablet [14] (&) estradiol 2 mg + dydrogesterone 10 mg tablet [14], 28
adrenaline (epinephrine) 150 microgram/0.3 mL injection, pen device
adrenaline (epinephrine) 150 microgram/0.3 mL injection, 0.3 mL pen device
adrenaline (epinephrine) 150 microgram/0.3 mL injection, 2 x 0.3 mL pen devices
adrenaline (epinephrine) 300 microgram/0.3 mL injection, pen device
adrenaline (epinephrine) 300 microgram/0.3 mL injection, 0.3 mL pen device
adrenaline (epinephrine) 300 microgram/0.3 mL injection, 2 x 0.3 mL pen devices
epoetin alfa 1000 international units / 0.5 mL injection, 0.5 mL syringe (medicinal product unit of use)
epoetin alfa 1000 units/0.5 mL injection, 6 x 0.5 mL syringes

Start Previous Page 3 of 14 Next End


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start